Arkolith/Insider Trading/VYGR/Form 4

Sandrock Alfred

President and CEO, DirectorVoyager Therapeutics, Inc. (VYGR) · full profile →Form 4 · filed Feb 22, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$97K
Net Open-Market Flow
-$97K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 21, 2024Sell(S)13K$7.46$97K335K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-24-026561) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML